Mr. Babeľa is teacher at college and also works as a healthcare expert in the field of evaluation of healthcare technologies since 2008. He graduated at the Trnava University of Trnava, at Open University Business School, London, UK, and at Sheffield University, Sheffield, UK. He has authored and co-authored more than 150 publications at home and abroad, and acquired practical skills during his more than 19 years of work in various healthcare positions. Prof. PhDr. Róbert Babeľa, PhD., MBA, is a member of the Board of the Council of the Universities of the Slovak Republic, a member of the Standing Working Group of the Accreditation Commission, Editor-in-Chief of the International Healthcare Journal, a member of several editorial boards or professional societies. He is currently working also on projects that are related to the quantification of actual direct and indirect costs from a payer perspective for a selected diagnosis in the Slovak Republic.
Since 2017, our analyzes have brought new insights on the most accurate cost data of selected diseases from the perspective of a sick patient or the entire population. However, this data is not just for a one-time presentation but provides guidance on where and by how to use resources that will still be limited. The presentation will show interesting insights into what we already know today and where we could go in the field of data and costs (not only) in healthcare.
Discussion of invited guests:
Adam Kozierkiewicz, JASPERS, European Investment Bank
Róbert Babeľa, Ústav zdravotníckych disciplín VŠZaSP sv. Alžbety
Jozef Benčík, SAS Slovakia
Daren Wilson, Roche Slovakia
Data economics in healthcare: examples from selected therapeutics areas | Medzinárodný kongres ITAPA 2019
The data economy in healthcare is closely linked to economic assessments in healthcare, which are increasingly being used outside the field of drug policy. Economic assessments in health care are de facto one part of the economy that deals with the efficiency, cost, value and behavior of the various components of the healthcare delivery system, especially in terms of resource consumption. In our short presentation, we will look at how the data economy - namely the direct and indirect costs of the selected diagnosis consumed - can influence the decision-making process in the healthcare delivery system from the perspective of key stakeholders.